mathpaperhelpcom logo

Our Services

Get 15% Discount on your First Order

Antidepressant MedicationsNameIndication, starting dose, target symptoms, and affected neurotransmittersHalf-life

Antidepressant Medications

Name

Indication, starting dose, target symptoms, and affected neurotransmitters

Half-life (T1/2)

CYP450 enzyme

Notes/Notable side effects/Precautions

SSRIs

Citalopram

(Celexa) 

Escitalopram (Lexapro) 

Fluoxetine

(Prozac) 

Fluvoxamine

(Luvox) 

Paroxetine

(Paxil) 

Sertraline

(Zoloft) 

SNRIs

Venlafaxine

(Effexor)

Desvenlafaxine

(Pristiq)

Duloxetine

(Cymbalta)

Other

Mirtazapine

(Remeron)

Trazadone

(Desyrel)

Vilazodone

(Viibryd)

Vortioxetine

(Trintellix)

Bupropion

(Wellbutrin)

This table includes the most commonly prescribed medications for depression. If there are other medications you would like to include for your reference you can add rows.

Mood Stabilizer Medications

Name  

Indication (FDA approval )& 

Starting dose  

Half-life (T1/2)  

CYP450 enzyme 

Notes/notable side effects/precautions/required diagnostics/therapeutic levels   

Lithium  

 

 

 

Carbamazepine (Tegretol) 

 

 

 

Valproic Acid  

 

 

 

Lamotrigine (Lamictal)  

 

 

 

This table focuses on the 4 medications mentioned in your Stahl (2021) textbook. You may add others you think are pertinent.  

Instructions:

For each medication listed, complete the following:

a. Provide indication, starting dose target symptoms, and affected neurotransmitters.

b. Include half-life and CYP 450 enzyme information.

c. List notable side effects and precautions.

d. Link notable side effects to the associated pathway or neurotransmitter.

2. 4 APA references needed with intext citation. Scholarly references must be within 5 years. For each medication listed, complete the following:

1. Provide indication, starting dose target symptoms, and affected neurotransmitters.

2. Include half-life and CYP 450 enzyme information.

3. List notable side effects and precautions

4. Link notable side effects to the associated pathway or neurotransmitter.

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

Neurotransmitter TableNeurotransmitter

Neurotransmitter Table Neuro transmitter Receptor Subtype Location/Function/Effects/symptoms of excess or deficit if applicable Distribution (ie: CNS/PNS, GI, vascular) Drug classes that target this neurotransmitter or receptor Specific medications that target this neurotransmitter or receptor Glutamate AMPA NMDA GABA GABA a GABA b Serotonin 5HT 5HT 1a 5HT 1B 5HT 1d

READ BELOW: 1. 1.  chose Atomoxetine for this patient.  2. List medication class and mechanism of action for the chosen medication. 1. According to Stahl

READ BELOW: 1. 1.  chose Atomoxetine for this patient.  2. List medication class and mechanism of action for the chosen medication. 1. According to Stahl (2021), this drug is a norepinephrine reuptake inhibitor and a selective norepinephrine inhibitor. Atomoxetine boosts norepinephrine/noradrenaline and increased dopamine in the prefrontal cortex. It also

ADHD TableDrug Name(include if IR, XR, ODT, LA)

ADHD Table Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediate-acting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) Dexmethylphenidate (Focalin) (D) Jornay PM Amphetamine (Adzenzys) Dextroamphetamine/amphetamine salts (Adderall, Mydayis )

NR 546 Week 7 Case Study- child and adolescentSubjective

NR 546 Week 7 Case Study- child and adolescent Subjective Objective The client is an 7-year-old male accompanied by his mother and 9-year-old brother. Client’s Chief Complaints: “My son is getting in trouble at school due to his behavioral. He has endless energy; he can’t sit still. When he plays,